Investigational Drug Information for Ceralasertib
✉ Email this page to a colleague
What is the development status for investigational drug Ceralasertib?
Ceralasertib is an investigational drug.
There have been 21 clinical trials for Ceralasertib.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2022.
The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are AstraZeneca, National Cancer Institute (NCI), and Parexel.
There are five US patents protecting this investigational drug and forty-two international patents.
Summary for Ceralasertib
| US Patents | 5 |
| International Patents | 42 |
| US Patent Applications | 50 |
| WIPO Patent Applications | 38 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 1 (2022-09-15) |
| Vendors | 48 |
Recent Clinical Trials for Ceralasertib
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Ch | AstraZeneca | Phase 2 |
| Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | AstraZeneca | Phase 2 |
| Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | IFOM, The FIRC Institute of Molecular Oncology | Phase 2 |
Clinical Trial Summary for Ceralasertib
Top disease conditions for Ceralasertib
Top clinical trial sponsors for Ceralasertib
US Patents for Ceralasertib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ceralasertib | ⤷ Sign Up | Chemical compounds | Astrazeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| Ceralasertib | ⤷ Sign Up | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| Ceralasertib | ⤷ Sign Up | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ceralasertib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ceralasertib | Argentina | AR081859 | 2030-06-11 | ⤷ Sign Up |
| Ceralasertib | Australia | AU2011263491 | 2030-06-11 | ⤷ Sign Up |
| Ceralasertib | Brazil | BR112012031561 | 2030-06-11 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
